Table 2.
Weaning outcome by primary diagnostic group
| n (%) | All patients n=262 (%) |
NMD-CWD n=104 (%) |
COPD n=51 (%) |
Postsurgical n=55 (%) |
ORRF n=14 (%) |
Other n=38 (%) |
|---|---|---|---|---|---|---|
| Self-ventilating | 100 (38.2) | 29 (27.9) | 24 (47.1) | 27 (49.1) | 6 (42.9) | 14 (36.8) |
| Nocturnal NIV | 63 (24.0) | 35 (33.7) | 9 (17.6) | 8 (14.5) | 6 (42.9) | 5 (13.2) |
| Nocturnal NIV and daytime use | 5 (1.9) | 1 (1.0) | 0 (0.0) | 2 (3.6) | 1 (7.1) | 1 (2.6) |
| Long-term tracheostomy | 56 (21.4) | 32 (30.8) | 5 (9.8) | 8 (14.5) | 0 (0.0) | 11 (28.9) |
| Death | 38 (14.5) | 7 (6.7) | 13 (25.5) | 10 (18.2) | 1 (7.1) | 7 (18.4) |
| Total weaned | 168 (64.1) | 65 (62.5) | 33 (64.7) | 37 (67.3) | 13 (92.9) | 20 (52.6) |
COPD, chronic obstructive pulmonary disease; CWD, chest wall disease; NIV, non-invasive ventilation; NMD, neuromuscular disease; ORRF, obesity-related respiratory failure.